Plus, it reduces exposure to crowded clinics, which is a bonus for anyone mindful of health safety
These substitutions protect against dipeptidyl peptidase-IV (DPP-IV) cleavage, the enzyme that destroys natural GHRH within minutes (Alba et al., J Med Chem 2006)
Key facts: First studied by researchers at the University of Zagreb (Croatia) in the early 1990s Over 100 peer-reviewed studies published since then (Kang et al., 2021) Administered via subcutaneous injection (most common), intramuscular injection, or orally Typical research dosages: 200-800 mcg per day Classification: Research peptide, not approved by the FDA for human use How it works (simplified): BPC-157 appears to promote healing by improving blood flow to damaged tissue, reducing inflammation, and supporting the body's natural repair processes
Its one of the cleanest GH-releasing peptides available, stimulating GH release without significantly affecting cortisol or prolactin levels
Nature 583 (7816), 441446